Literature DB >> 6180502

Plasma beta-thromboglobulin in severe infection.

V Rasi, E Ikkala, V Valtonen.   

Abstract

The plasma concentration of beta-thromboglobulin was serially measured in nine patients with septicemia, ten patients with pneumonia and five thrombo- and granulocytopenic patients with acute leukemia. Six patients with septicemia out of the eight studied on days 1-3 and all eight patients studied 7-14 days after onset had an abnormal high beta-thromboglobulin level. One patient with pneumonia out of six studied on days 1-3 and six out of nine studied on 7-14 days after onset had an abnormal high value. A rising trend in plasma beta-thromboglobulin with the highest mean levels at one to two weeks after onset was common to both groups. Positive ethanol gelation, increased level of fibrin/fibrinogen degradation products, decreased antithrombin III, increased FVIII complex and disproportionate ratio of FVIII:C to FVIIIR:Ag were common in both groups in the early stages of the disease. All the five patients with leukemia had a lower than normal beta-thromboglobulin level throughout the study but showed in the coagulation parameters changes similar to those observed in the other groups. Judging from the commonness of abnormal beta-thromboglobulin values in the two first patient groups, low grade platelet activation is a normal response in severe infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180502     DOI: 10.1016/0049-3848(82)90291-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients.

Authors:  J Syrjänen; V V Valtonen; M Iivanainen; M Kaste; J K Huttunen
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-23

2.  Association between dental health and acute myocardial infarction.

Authors:  K J Mattila; M S Nieminen; V V Valtonen; V P Rasi; Y A Kesäniemi; S L Syrjälä; P S Jungell; M Isoluoma; K Hietaniemi; M J Jokinen
Journal:  BMJ       Date:  1989-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.